Identification of Optimal Insertion Site in Recombinant Newcastle Disease Virus (rNDV) Vector Expressing Foreign Gene to Enhance Its Anti-Tumor Effect

作者: Ziye Pan , Jinjiao He , Lubna M. Rasoul , Yunye Liu , Ruixiang Che

DOI: 10.1371/JOURNAL.PONE.0164723

关键词:

摘要: Recombinant Newcastle disease virus (rNDV) is tumor selective and intrinsically oncolytic, which has been developed as a vector to express exogenous genes enhance its oncolytic efficacy. Our previous studies found that insertion sites of foreign gene in rNDV affected expression anti-tumor activities. However, the optimal site for remains unknown. In this study, we inserted enhanced green fluorescence protein (EGFP) IL2 into four different intergenic regions using reverse genetics technology. Recombinants rNDV-EGFPs rNDV-IL2s were successfully rescued, displayed similar growth kinetics with parental virus. Both EGFP mRNA levels most abundant HepG2 cells, when was between NP/P rNDV. Similarly, IL-2 expressed by cells infected rNDV-IL2 highest, site. To test whether these rNDVs higher could induce stronger response, treated H22-oxter-tumor-bearing C57BL/6J mice then examined The results showed rNDV-IL2-NP/P had strongest inhibition murine hepatoma carcinoma tumors. splenocytes isolated from reached highest degrees CD4+ T CD8+ cells. addition, animals' survival rate rNDV-IL2-NP/P-treated group than other groups. Taken together, demonstrate NP P junction rNDV's effects.

参考文章(19)
Meng, Li, Kan, Sun, Zhuo-yue, Shi-fu, Hai-yan, Li-li, Xiao, Liu, Guo-hua, Bing-guo, Lei, Huang, Piao, Yu-hang, Wang, Yang, Xiang-wei, Induction of Effective Antitumor Immune Response by Combined Administration of hIL-18 and NDV HN 高等学校化学研究:英文版. ,vol. 27, pp. 836- 840 ,(2011)
Pascal Buijs, Stefan van Nieuwkoop, Vincent Vaes, Ron Fouchier, Casper van Eijck, Bernadette Hoogen, Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma Viruses. ,vol. 7, pp. 2980- 2998 ,(2015) , 10.3390/V7062756
Fu-Liang Bai, Yin-Hang Yu, Hui Tian, Gui-Ping Ren, Hui Wang, Bing Zhou, Xiao-Hui Han, Qing-Zhong Yu, De-Shan Li, Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy Cancer Biology & Therapy. ,vol. 15, pp. 1226- 1238 ,(2014) , 10.4161/CBT.29686
FL Bai, H Tian, QZ Yu, GP Ren, DS Li, None, Expressing foreign genes by Newcastle disease virus for cancer therapy Molecular Biology. ,vol. 49, pp. 171- 178 ,(2015) , 10.1134/S0026893315020028
Ashraf S. Ibrahim, Guanpingsheng Luo, Teclegiorgis Gebremariam, Hongkyu Lee, Clint S. Schmidt, John P. Hennessey, Samuel W. French, Michael R. Yeaman, Scott G. Filler, John E. Edwards, NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response. Vaccine. ,vol. 31, pp. 5549- 5556 ,(2013) , 10.1016/J.VACCINE.2013.09.016
Chun-Xiao Zhang, Long-Wei Ye, Ying Liu, Xiao-Ya Xu, Dan-Rui Li, Yan-Qing Yang, Lu-Lu Sun, Jie Yuan, Antineoplastic activity of Newcastle disease virus strain D90 in oral squamous cell carcinoma Tumor Biology. ,vol. 36, pp. 7121- 7131 ,(2015) , 10.1007/S13277-015-3433-Z
Yunzhou Wu, Shijun Yan, Zheng Lv, Lin Chen, Jingshu Geng, Jinjiao He, Qingzhong Yu, Jiechao Yin, Guiping Ren, Deshan Li, Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy. Technology in Cancer Research & Treatment. ,vol. 13, pp. 169- 175 ,(2014) , 10.7785/TCRT.2012.500356